ACADIA PHARMACEUTICALS INC. Earnings Per Share, Basic and Diluted
ACADIA PHARMACEUTICALS INC. (ACAD) reported Earnings Per Share, Basic and Diluted of -$0.70 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-05
- ACADIA PHARMACEUTICALS INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.70.
- ACADIA PHARMACEUTICALS INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.27.
- ACADIA PHARMACEUTICALS INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.09.
- ACADIA PHARMACEUTICALS INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.27.
- ACADIA PHARMACEUTICALS INC. earnings per share, basic and diluted for fiscal 2021 was -$1.05.
- ACADIA PHARMACEUTICALS INC. earnings per share, basic and diluted for fiscal 2020 was -$1.79.
- ACADIA PHARMACEUTICALS INC. earnings per share, basic and diluted for fiscal 2019 was -$1.60.
- ACADIA PHARMACEUTICALS INC. earnings per share, basic and diluted for fiscal 2018 was -$1.94.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2022-03-31 | -$0.70 10-Q · filed 2022-05-05 | ||||
| 2021-12-31 | -$0.27 10-K · filed 2022-03-01 | -$1.05 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$0.09 10-K · filed 2022-03-01 | -$0.78 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | -$0.27 10-K · filed 2022-03-01 | -$0.69 10-Q · filed 2021-08-05 | |||
| 2021-03-31 | -$0.42 10-Q · filed 2022-05-05 | ||||
| 2020-12-31 | -$1.79 10-K · filed 2022-03-01 | ||||
| 2020-12-30 | -$0.42 10-K · filed 2022-03-01 | ||||
| 2020-09-30 | -$0.05 10-K · filed 2022-03-01 | -$0.54 10-Q · filed 2020-11-04 | -$1.37 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | -$0.27 10-K · filed 2022-03-01 | -$0.83 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | -$0.57 10-K · filed 2022-03-01 | ||||
| 2019-12-31 | -$0.34 10-K · filed 2021-02-25 | -$1.60 10-K · filed 2022-03-01 | |||
| 2019-09-30 | -$0.29 10-K · filed 2021-02-25 | -$1.26 10-Q · filed 2020-11-04 | |||
| 2019-06-30 | -$0.38 10-K · filed 2021-02-25 | -$0.97 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | -$0.59 10-K · filed 2021-02-25 | ||||
| 2018-12-31 | -$0.50 10-K · filed 2020-02-27 | -$1.94 10-K · filed 2021-02-25 | |||
| 2018-09-30 | -$0.50 10-K · filed 2020-02-27 | -$1.44 10-Q · filed 2019-10-31 | |||
| 2018-06-30 | -$0.51 10-K · filed 2020-02-27 | -$0.94 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | -$0.44 10-K · filed 2020-02-27 | ||||
| 2017-12-31 | -$0.55 10-K · filed 2019-02-27 | -$2.36 10-K · filed 2020-02-27 | |||
| 2017-09-30 | -$0.53 10-K · filed 2019-02-27 | -$1.81 10-Q · filed 2018-11-06 | |||
| 2017-06-30 | -$0.55 10-K · filed 2019-02-27 | -$1.27 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | -$0.72 10-K · filed 2019-02-27 | ||||
| 2016-12-31 | -$0.65 10-K · filed 2018-02-27 | -$2.34 10-K · filed 2019-02-27 | |||
| 2016-09-30 | -$0.61 10-K · filed 2018-02-27 | -$1.69 10-Q · filed 2017-11-07 | |||
| 2016-06-30 | -$0.63 10-K · filed 2018-02-27 | -$1.08 10-Q · filed 2017-08-08 | |||
| 2016-03-31 | -$0.45 10-K · filed 2018-02-27 | ||||
| 2015-12-31 | -$0.45 10-K · filed 2017-02-28 | -$1.63 10-K · filed 2018-02-27 | |||
| 2015-09-30 | -$0.39 10-K · filed 2017-02-28 | -$1.18 10-Q · filed 2016-11-07 | |||
| 2015-06-30 | -$0.39 10-K · filed 2017-02-28 | -$0.80 10-Q · filed 2016-08-04 | |||
| 2015-03-31 | -$0.40 10-K · filed 2017-02-28 | ||||
| 2014-12-31 | -$0.28 10-K · filed 2016-02-29 | -$0.95 10-K · filed 2017-02-28 | |||
| 2014-09-30 | -$0.25 10-K · filed 2016-02-29 | -$0.66 10-Q · filed 2015-11-05 | |||
| 2014-06-30 | -$0.22 10-K · filed 2016-02-29 | -$0.41 10-Q · filed 2015-08-06 | |||
| 2014-03-31 | -$0.19 10-K · filed 2016-02-29 | ||||
| 2013-12-31 | -$0.13 10-K · filed 2015-02-26 | -$0.44 10-K · filed 2016-02-29 | |||
| 2013-09-30 | -$0.12 10-K · filed 2015-02-26 | -$0.31 10-Q · filed 2014-11-10 | |||
| 2013-06-30 | -$0.11 10-K · filed 2015-02-26 | -$0.19 10-Q · filed 2014-08-05 | |||
| 2013-03-31 | -$0.08 10-K · filed 2015-02-26 | ||||
| 2012-12-31 | -$0.11 10-K · filed 2014-02-27 | -$0.38 10-K · filed 2015-02-26 | |||
| 2012-09-30 | -$0.04 10-K · filed 2014-02-27 | -$0.26 10-Q · filed 2013-11-06 | |||
| 2012-06-30 | -$0.10 10-K · filed 2014-02-27 | -$0.22 10-Q · filed 2013-08-06 | |||
| 2012-03-31 | -$0.12 10-K · filed 2014-02-27 | ||||
| 2011-12-31 | -$0.10 10-K · filed 2013-03-12 | -$0.44 10-K · filed 2014-02-27 | |||
| 2011-09-30 | -$0.10 10-K · filed 2013-03-12 | -$0.34 10-Q · filed 2012-11-05 | |||
| 2011-06-30 | -$0.12 10-K · filed 2013-03-12 | -$0.24 10-Q · filed 2012-08-08 | |||
| 2011-03-31 | -$0.12 10-K · filed 2013-03-12 | ||||
| 2010-09-30 | -$0.11 10-Q · filed 2011-11-09 | -$0.37 10-Q · filed 2011-11-09 | |||
| 2010-06-30 | -$0.11 10-Q · filed 2011-08-10 | -$0.25 10-Q · filed 2011-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |